Discusses KCC2 Deep Dive and Pipeline Advances in CNS Disorders April 14, 2026 9:30 AM EDTCompany ParticipantsMeg Alexander ...

Marks First In-Human Clinical Study Demonstrating the Value of Immuno-Pharmacodynamics in the Assessment of Radioligand Therapy -- Novigenix AI Liquid Biopsy Platform Identifies Immune Activation ...

Fatty liver is an increasingly common disease that can progress toward more severe forms, involving inflammation, fibrosis, and, in some cases, cirrhosis and liver cancer. While it is known that a ...

Natural products have historically served as a vital source of chemotherapeutic agents, laying the foundation for many standard-of-care drugs. However, the ...

CETI’s previous scientific findings, aided by artificial intelligence, have already revealed a strikingly intricate system of ...

The next important milestone for AI research is to automate model development. Every advance in reasoning, language, and perception is, in some sense, a step toward that goal. However, the path to ...

The AI version of Meta's CEO is the first serious test of whether executive presence can be automated — and Meta rarely keeps ...

Valo Health, Inc. ("Valo"), a pioneer in the use of human data and AI to accelerate drug discovery and development, today announced the appointment of Chris Anagnostopoulos, PhD, C.Stat, to the newly ...

Mixed-age Grouping, Club Goals, Knowledge Sharing, Innovative Behavior, Mediating Effect Yang, Y. , Liu, S. and Wang, J. (2026) The Effect of Club Goals on Innovative Behavior in Elementary School ...

Vera Simone Nova has received a 2026 Global Recognition Award for her decades of independent research into human perception and cognition, ...